News & Updates

Neurodevelopment appears to be significantly delayed at up to 4 years of age in boys who are born to mothers with gestational diabetes mellitus (GDM), reports a recent study.

Prepregnancy intakes of total fat, unsaturated fat, and monounsaturated fatty acid (MUFA) do not appear to contribute to hypertensive disorders of pregnancy (HDP), but trans fatty acid (TFA) shows a positive association with HDP, reports a study.

Maintenance therapy with the PARP* inhibitor niraparib led to a sustained and durable progression-free survival (PFS), regardless of biomarker status, in patients with primary advanced ovarian cancer who responded to platinum-based chemotherapy, an updated analysis of the phase III PRIMA/ENGOT-OV26/GOG-3012 trial has shown.

A combination regimen comprising apatinib, a small-molecule TKI*, and pegylated liposomal doxorubicin (PLD) led to improved progression-free survival (PFS) in women with platinum-resistant recurrent ovarian cancer (PROC), results of the APPROVE trial suggest.

Among older patients with metastatic breast cancer, first-line treatment with reduced-dose eribulin mesylate is reasonably safe but yields a low disease control rate, reports a recent phase II trial.